Cargando…

Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report

BACKGROUND: Tocilizumab is a humanized monoclonal antibody that acts as an IL-6 receptor antagonist. Intravenous tocilizumab is considered an option for children with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis. In contrast, the potential of subcutaneous drug use with this i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burlo, Francesca, Tumminelli, Cristina, Pastore, Serena, Stocco, Gabriele, Curci, Debora, Lucafò, Marianna, Tommasini, Alberto, Taddio, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496382/ https://www.ncbi.nlm.nih.gov/pubmed/37700264 http://dx.doi.org/10.1186/s12969-023-00883-y

Ejemplares similares

Erythropoietic protoporphyria: case reports for clinical and therapeutic hints
por: Tumminelli, Cristina, et al.
Publicado: (2023)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Chronic limping in childhood, what else other than juvenile idiopathic arthritis: a case series
por: Tumminelli, Cristina, et al.
Publicado: (2023)

Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis
por: Leclercq, Mathilde, et al.
Publicado: (2023)

Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease
por: Curci, Debora, et al.
Publicado: (2022)

Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience
por: Maccora, Ilaria, et al.
Publicado: (2022)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021)

A Validated HPLC–Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside
por: Franzin, Martina, et al.
Publicado: (2022)

Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Ultrasonographic Assessment for Tenosynovitis in Juvenile Idiopathic Arthritis with Ankle Involvement: Diagnostic and Therapeutic Significance
por: Della Paolera, Sara, et al.
Publicado: (2022)

Infectious Uveitis
por: Powell, Cynthia C., et al.
Publicado: (2006)

Microbiota and Drug Response in Inflammatory Bowel Disease
por: Franzin, Martina, et al.
Publicado: (2021)

5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2014)

Chronic recurrent multifocal osteomyelitis: experience from a single pediatric rheumatology center over the past ten years
por: Pastore, Serena, et al.
Publicado: (2014)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012)

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients
por: Lucafò, Marianna, et al.
Publicado: (2019)

Emergent Infectious Uveitis
por: Khairallah, Moncef, et al.
Publicado: (2009)

Infectious uveitis in Virginia
por: Engelhard, Stephanie B, et al.
Publicado: (2015)

Infectious uveitis: An enigma
por: Majumder, Parthopratim Dutta, et al.
Publicado: (2017)

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway
por: Lucafò, Marianna, et al.
Publicado: (2020)

Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD
por: Lucafò, Marianna, et al.
Publicado: (2019)

Patient-derived organoids for therapy personalization in inflammatory bowel diseases
por: Lucafò, Marianna, et al.
Publicado: (2022)

Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
por: Iannone, Claudia, et al.
Publicado: (2023)

Clinical significance of hyper-IGA in a pediatric laboratory series
por: Pastore, Serena Ifmach, et al.
Publicado: (2014)

A toddler with an unusually severe polyarticular arthritis and a lung involvement: a case report
por: Basile, Pietro, et al.
Publicado: (2022)

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
por: Lauper, Kim, et al.
Publicado: (2018)

Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
por: Negoescu, Andra F., et al.
Publicado: (2014)

Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients
por: Tang, Kuo-Tung, et al.
Publicado: (2023)

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2019)

Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis
por: Sato, Tomohito, et al.
Publicado: (2014)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors
por: Pin, Alessia, et al.
Publicado: (2020)

Correction: Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
Publicado: (2019)

Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events
por: Genova, Elena, et al.
Publicado: (2019)

Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease
por: Di Silvestre, Alessia, et al.
Publicado: (2019)

Sex and Reproduction in the Transmission of Infectious Uveitis
por: Davis, Janet L.
Publicado: (2014)

Rituximab for non-infectious Uveitis and Scleritis
por: Ng, Caleb C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kdelfe32fb8v2h5o3mgd3bklsl